Le Lézard
Classified in: Science and technology, Business
Subject: JVN

Global CDMO partners with Kneat to Digitize their Validation work Processes


LIMERICK, Ireland, July 22, 2019 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat") is pleased to announce that a global contract development and manufacturing organization ("CDMO") has selected Kneat's platform to digitize their commissioning, qualification and validation work processes. This customer contracted with Kneat for on-premise perpetual licenses on July 12, 2019 and is expected to go live at a European site on multiple processes by the end of the year.  Expansion to all global sites is expected in the future.

Logo: kneat.com, inc. (CNW Group/kneat.com, inc.)

"We're happy to be fulfilling such a key role within this customer's highly regulated GMP manufacturing facility," said Eddie Ryan, Chief Executive Officer of Kneat. "Partnering with this global organization in the growing CDMO space represents an important opportunity for Kneat and entry into a key market within the life sciences industry."

Kneat continues to expand its customer pipeline and will report on further developments as they occur.

About Kneat

Kneat, a Canadian company with operational headquarters in Limerick, Ireland, develops and markets the next generation Kneat Gx software platform.  Multiple business work processes can be configured on the platform from equipment to computer system validation, through to quality document management.  Kneat's software allows users to author, review, approve, execute testing online, manage any exceptions and post approve final deliverables in a controlled FDA 21 CFR Part 11/ Eudralex Annex 11 compliant platform.  Macro and micro report dashboards enable powerful oversight into all systems, projects and processes globally.  Customer case studies are reporting productivity improvements in excess of 100% and a higher data integrity and compliance standard.  For more information visit www.kneat.com.

Cautionary and Forward-Looking Statements

Except for the statements of historical fact contained herein, certain information presented constitutes "forward-looking information" within the meaning of applicable Canadian securities laws.  Such forward-looking information, includes, but is not limited to, the relationship between Kneat and the customer, Kneat's business development activities, the use and implementation timelines of Kneat's software within the customer's validation processes, the ability and intent of the customer to scale the use of Kneat's software within the customer's organization and the compliance of Kneat's platform under regulatory audit and inspection.  While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties.  As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events.  These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties.  Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws.  Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement.  Continued reliance on forward-looking statements is at an investors' own risk.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

SOURCE kneat.com, inc.


These press releases may also interest you

at 08:10
bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced David Elzi, Ph.D., has been named Vice President of...

at 08:10
Plus, a global leader in autonomous driving software solutions, announced today that it has been recognized as a Gold winner of the 2024 Edison Awards for its supervised autonomy software solution, PlusDrive®, in the Innovative Services & Software...

at 08:10
Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced the availability of Over the Counter ("OTC") Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg, following Abbreviated New Drug Application ("ANDA") approval from the...

at 08:10
BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform announced a collaboration with Janssen Biotech Inc., a Johnson & Johnson company. This strategic...

at 08:10
Bitwarden, the credential management leader, today announced the results of its fourth annual World Password Day survey, in advance of World Password Day on May 2, 2024. Bitwarden surveyed 2,400 individuals from the US, UK, Australia, France,...

at 08:10
BigCommerce , a leading Open SaaS ecommerce platform for fast-growing and established B2C and B2B brands, today announced it has been named a Leader in the new IDC MarketScape: Worldwide Enterprise B2C Digital Commerce Applications 2024 Vendor...



News published on and distributed by: